FDA MedWatch – Limar Hand Sanitizer Packaged in 4.0 oz Bottles by Ardil Comercial:

TOPIC: Limar Hand Sanitizer Packaged in 4.0 oz Bottles by Ardil Comercial: Recall – Because They Resemble Drink Containers

AUDIENCE: Consumer, Health Professional

ISSUE: Ardil Comercial is recalling one lot of Limar Hand Sanitizer, packaged in 4.0 oz bottles because they are packaged in containers that resemble water bottles and pose a risk of ingestion.

Ingesting hand sanitizer, which is intended for topical use, could potentially result in alcohol toxicity. Symptoms of alcohol toxicity may range from lack of coordination, slowed or slurred speech, drowsiness to coma, which can be fatal. Furthermore, ingesting alcohol can affect the brain and cause impaired driving or operating heavy machinery. Alcohol can also interact with numerous drugs which may result in serious adverse effects. Ingesting alcohol by people with alcohol addiction may interfere with maintaining abstinence. Additionally, people with alcohol addiction may seek large amounts of ethanol-based hand sanitizers as a substitute.

To date, Ardil Comercial has not received any reports of adverse events related to this recall.

For more information about this recall, click on the red button “Read Recall” below.

BACKGROUND: Limar Hand Sanitizer is intended to be applied topically to help reduce bacteria on the skin that could cause diseases when soap and water are not available.

RECOMMENDATIONS: 

• Consumers and distributors that have the product which is being recalled should return to place of purchase.
• Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.